| __timestamp | Blueprint Medicines Corporation | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 1488000000 |
| Thursday, January 1, 2015 | 48588000 | 1525000000 |
| Friday, January 1, 2016 | 81131000 | 2111000000 |
| Sunday, January 1, 2017 | 144687000 | 1848000000 |
| Monday, January 1, 2018 | 243621000 | 1213000000 |
| Tuesday, January 1, 2019 | 331450000 | 1010000000 |
| Wednesday, January 1, 2020 | 326860000 | 997000000 |
| Friday, January 1, 2021 | 601033000 | 967000000 |
| Saturday, January 1, 2022 | 477419000 | 838000000 |
| Sunday, January 1, 2023 | 427720000 | 953000000 |
| Monday, January 1, 2024 | 341433000 | 998000000 |
Data in motion
In the competitive world of pharmaceuticals, investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Teva Pharmaceutical Industries Limited and Blueprint Medicines Corporation have shown contrasting approaches to R&D spending. From 2014 to 2023, Teva consistently outspent Blueprint, with its R&D expenses peaking in 2016 at over twice the amount of Blueprint's highest expenditure in 2021. However, Blueprint's R&D investment grew by an impressive 1,240% from 2014 to 2021, reflecting its commitment to innovation. In contrast, Teva's R&D spending decreased by 36% from its 2016 peak to 2023. This divergence highlights the strategic differences between an established giant and a rising star in the pharmaceutical industry. As Blueprint continues to ramp up its R&D efforts, it will be interesting to see how this impacts its market position in the coming years.
AbbVie Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Sanofi vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
R&D Insights: How Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited Allocate Funds
Teva Pharmaceutical Industries Limited or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Teva Pharmaceutical Industries Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
R&D Spending Showdown: Teva Pharmaceutical Industries Limited vs PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Research and Development Investment: Blueprint Medicines Corporation vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Blueprint Medicines Corporation and PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Veracyte, Inc.
R&D Spending Showdown: Blueprint Medicines Corporation vs Evotec SE